Duncan A. Gordon

3.4k total citations · 1 hit paper
59 papers, 2.6k citations indexed

About

Duncan A. Gordon is a scholar working on Rheumatology, Immunology and Pharmacology. According to data from OpenAlex, Duncan A. Gordon has authored 59 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 15 papers in Immunology and 13 papers in Pharmacology. Recurrent topics in Duncan A. Gordon's work include Inflammatory mediators and NSAID effects (10 papers), Systemic Lupus Erythematosus Research (9 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Duncan A. Gordon is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Systemic Lupus Erythematosus Research (9 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Duncan A. Gordon collaborates with scholars based in United Kingdom, Canada and Denmark. Duncan A. Gordon's co-authors include M. A. Ogryzlo, M.A. Bray, Murray B. Urowitz, H A Smythe, Barry E. Koehler, John E. Morley, Arthur Bookman, I. Broder, W. Pruzanski and A.M.E. Nouri and has published in prestigious journals such as Nature, Annals of Internal Medicine and Annals of the New York Academy of Sciences.

In The Last Decade

Duncan A. Gordon

58 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The bimodal mortality pattern of systemic lupus erythematosus

1976 756 citations Murray B. Urowitz, Barry E. Koehler et al. The American Journal of Medicine profile →

Peers

Duncan A. Gordon

RHEUM

IMMUN

PHARM

PFM

M.W. Greaves United Kingdom

Hiroaki Matsuno Japan

Jer-Yuarn Wu Taiwan

Yukitaka Ueki Japan

Kazuhiro Dohi Japan

Kathleen Haines United States

Wan‐Hee Yoo South Korea

Yuan-Tsong Chen Taiwan

Chul‐Soo Cho South Korea

Richard I. Rynes United States

M.W. Greaves United Kingdom

Duncan A. Gordon

1.2k ×0.9

RHEUM

941 ×0.9

IMMUN

457 ×0.9

PHARM

383 ×1.0

586 ×1.7

PFM

Citations per year, relative to Duncan A. Gordon Duncan A. Gordon (= 1×) peers M.W. Greaves

Countries citing papers authored by Duncan A. Gordon

Since Specialization

Citations

This map shows the geographic impact of Duncan A. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan A. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan A. Gordon more than expected).

Fields of papers citing papers by Duncan A. Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan A. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan A. Gordon. The network helps show where Duncan A. Gordon may publish in the future.

Co-authorship network of co-authors of Duncan A. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Duncan A. Gordon. A scholar is included among the top collaborators of Duncan A. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan A. Gordon. Duncan A. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gordon, Duncan A.. (2008). Canadian Rheumatology Association Meeting. The Journal of Rheumatology. 35(6). 1170–1170. 1 indexed citations

Gordon, Duncan A.. (2003). Fibromyalgia--real or imagined?. PubMed. 30(8). 1665–1665. 14 indexed citations

Gordon, Duncan A.. (1999). Chronic widespread pain as a medico-legal issue. Best Practice & Research Clinical Rheumatology. 13(3). 531–543. 6 indexed citations

Gordon, Duncan A.. (1998). Rheumatoid arthritis--new treatments, and a new look at medical ethics.. PubMed. 25(11). 2049–2049. 2 indexed citations

Gordon, Duncan A., et al.. (1996). Silica and progressive systemic sclerosis (scleroderma): Evidence for workers' compensation policy. American Journal of Industrial Medicine. 29(5). 533–538. 2 indexed citations

Bolton, C., Darien Parker, Julie McLeod, Duncan A. Gordon, & J.L. Turk. (1985). Correlation between prostaglandin and thromboxane levels and clinical signs in cyclosporine A-treated guinea pigs with acute experimental allergic encephalomyelitis. Immunopharmacology. 9(3). 147–153. 2 indexed citations

Edwards, Mary C., F.J. Evans, Marilyn Barrett, & Duncan A. Gordon. (1985). Structural correlations of phorbol-ester-induced stimulation of PGE2 production by human rheumatoid synovial cells. Inflammation. 9(1). 33–38. 7 indexed citations

Edwards, Mary C., A.M.E. Nouri, Duncan A. Gordon, & F.J. Evans. (1983). Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.. Molecular Pharmacology. 23(3). 703–708. 12 indexed citations

Khanna, Ramesh, et al.. (1982). MANAGEMENT OF END-STAGE SCLERODERMA RENAL DISEASE WITH CONTINUOUS AMBULATORY PERITONEAL DIALYSIS - REPORT OF TWO CASES. Peritoneal Dialysis International. 2(4). 174–177. 1 indexed citations

10.

Gordon, Duncan A., et al.. (1981). SELECTIVE INHIBITION OF THROMBOXANE BIOSYNTHESIS IN HUMAN BLOOD MONONUCLEAR CELLS AND THE EFFECTS ON MITOGEN‐STIMULATED LYMPHOCYTE PROLIFERATION. British Journal of Pharmacology. 74(2). 469–475. 15 indexed citations

11.

Gordon, Duncan A., D C Henderson, & John Westwick. (1979). EFFECTS OF PROSTAGLANDINS E₂ AND I₂ ON HUMAN LYMPHOCYTE TRANSFORMATION IN THE PRESENCE AND ABSENCE OF INHIBITORS OF PROSTAGLANDIN BIOSYNTHESIS. British Journal of Pharmacology. 67(1). 17–22. 28 indexed citations

12.

Gordon, Duncan A., et al.. (1978). Comparison of osteitis condensans ilii and ankylosing spondylitis in female patients: Clinical, radiological and HLA typing characteristics. Journal of Chronic Diseases. 31(3). 171–181. 9 indexed citations

13.

Gladman, Dafna D., et al.. (1976). Pericardial fluid analysis in scleroderma (systemic sclerosis). The American Journal of Medicine. 60(7). 1064–1068. 17 indexed citations

14.

Gordon, Duncan A., M.A. Bray, & John E. Morley. (1976). Control of lymphokine secretion by prostaglandins. Nature. 262(5567). 401–402. 334 indexed citations

15.

Hunter, Thomas, Murray B. Urowitz, Duncan A. Gordon, H A Smythe, & M. A. Ogryzlo. (1975). Azathioprine in rheumatoid arthritis. Arthritis & Rheumatism. 18(1). 15–20. 58 indexed citations

16.

Urowitz, Murray B., Duncan A. Gordon, H A Smythe, W. Pruzanski, & M. A. Ogryzlo. (1973). Azathioprine in Rheumatoid Arthritis A Double‐Blind, Cross‐Over Study. Arthritis & Rheumatism. 16(3). 411–418. 72 indexed citations

17.

Gordon, Duncan A., W. Pruzanski, M. A. Ogryzlo, & Hugh Little. (1973). Amyloid arthritis simulating rheumatoid disease in five patients with multiple myeloma. The American Journal of Medicine. 55(2). 142–154. 67 indexed citations

18.

Gordon, Duncan A., David Bell, Reuben Baumal, & I. Broder. (1969). Studies into the occurrence of soluble antigen-antibody complexes in disease. IV. Correlation between the rheumatoid biologically active factor and the clinical features of rheumatoid arthritis.. PubMed. 5(1). 57–66. 22 indexed citations

19.

Gordon, Duncan A., et al.. (1967). The rheumatic disease unit (R.D.U.) concept. Arthritis & Rheumatism. 10(5). 479–485. 4 indexed citations

20.

Gordon, Duncan A., Arthur Z. Eisen, & John H. Vaughan. (1966). Studies on urinary γ‐globulins in patients with rheumatoid arthritis. Arthritis & Rheumatism. 9(4). 575–588. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact